Dantrolene sodium - Drug Shortage Information

Public shortage context is available across 3 visible exact NDC pages for this generic drug family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Historical shortage references are available across related Dantrolene sodium presentations from multiple manufacturers.

  • 0 current shortage context pages.
  • 3 historical shortage context pages.
  • 3 manufacturers represented.

Related research paths

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
Ryanodex, dantrolene sodium - Dantrolene sodium 250 mg / 5mL Injection 20 mLPRN Watchlist
NDC 42367-0540-32 | 1 Vial | Eagle Pharmaceuticals, Inc.
42367-0540-32Eagle Pharmaceuticals, Inc.Historical shortage context
Dantrium - Dantrolene sodium 20 mg / 60mL Injection 60 mL
NDC 42023-0123-06 | 6 Vial | Par Health USA, LLC
42023-0123-06Par Health USA, LLCHistorical shortage context
Revonto - Dantrolene sodium 20 mg / 60mL Injection 60 mL
NDC 78670-0003-67 | 6 Vial, Glass | Uswm, Llc
78670-0003-67Uswm, LlcHistorical shortage context

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.